Table 2 Association between the main outcomes of the cervical screening tests based on visual inspection methods and HIV status in Abidjan, Côte d'Ivoire.

Eligible women who underwent a cervical screening with acetic acid and Lugol iodine (n = 4,046)

Positive VI†

< 10^-4

< 10^-4

HIV-negative

41/1,048

1

1

HIV-positive

268/2,998

2.41

1.72-3.37

2.28

1.61-3.23

Positive VIA

< 10^-4

< 10^-4

HIV-negative

20/1,048

1

1

HIV-positive

230/2,998

4.27

2.69-6.78

4.02

2.49-6.48

Positive VILI

< 10^-4

< 10^-4

HIV-negative

37/1,048

1

1

HIV-positive

255/2,998

2.54

1.79-3.61

2.34

1.63-3.36

Clinical cervicitis

< 10^-3

< 10^-4

HIV-negative

64/1,048

1

1

HIV-positive

290/2,998

1.65

1.24-2.18

1.86

1.38-2.50

No visualisation of the SCJ

0.47

0.45

HIV-negative

24/1,048

1

1

HIV-positive

81/2,998

1.18

0.75-1.88

1.2

0.74-1.94

CIN of any grade‡

10^-3

< 10^-2

HIV-negative

20/1,048

1

1

HIV-positive

132/2,998

2.36

1.47-3.81

2.13

1.31-3.45

Positively screened women with acetic acid and/or Lugol iodine (n = 309)

Multiple lesions

0.08

0.10

HIV-negative

6/41

1

1

HIV-positive

74/268

2.25

0.90-5.51

2.13

0.85-5.35

Lesions with several

< 10^-4

< 10^-4

quadrants of the cervix

involved

HIV-negative

14/41

1

1

HIV-positive

184/268

4.22

2.11-8.47

4.49

2.17-9.28

Extension to the endocervical canal

< 10^-2

0.02

HIV-negative

11/41

1

1

HIV-positive

134/268

2.64

1.27-5.50

2.42

1.15-5.08

Patients lost to follow-up∫

0.32

0.26

HIV-negative

5/41

1

1

HIV-positive

50/268

1.65

0.62-4.42

1.89

0.63-5.69